Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment
Lihao Shi et al · Wiley · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, L. S. E. (2026). Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment. https://doi.org/10.1155/mi/4823996
MLA
al, Lihao Shi et. "Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment." 2026. https://doi.org/10.1155/mi/4823996.
Chicago
al, Lihao Shi et. 2026. "Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment.". https://doi.org/10.1155/mi/4823996.
Harvard
al, L. S. E. 2026, Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment, Wiley, available at: https://doi.org/10.1155/mi/4823996 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Evaluating Ribosomal Protein L19 mRNA as a Biomarker in Ulcerative Colitis: Implications for Severity Assessment
- Autor / colaboradores
- Lihao Shi et al
- Editorial
- Wiley
- Año de publicación
- 2026
- ISSN
- 1466-1861
- ISSN
- 1466-1861
- Idioma
- eng